Professor of Cardiovascular Medicine, Honorary Consultant Cardiologist. Specialist adult cardiovascular care: putting research into practice to benefit patients
#PAD#MedEd
In 2023 an estimated 122 million people worldwide had lower extremity peripheral arterial disease. Two thirds of its DALYs were attributable to modifiable risk factors, notably #kidney dysfunction, high fasting plasma #glucose, #tobacco & high #BMI. #cardiotwitter
Do you know what your blood pressure numbers mean?
The NHS is urging over 40s to know their numbers amid 'alarming' rise in high blood pressure emergencies.
Use our online tool to understand what your reading means, and what you can do next.
➡️ https://t.co/fGsErdt4z1
This review argues that road traffic noise is consistently & dose dependently associated with ischaemic heart disease, #stroke, #heartfailure & #diabetes.
Yet noise is largely absent from risk tools & guidelines.
https://t.co/fRwQYdGGi6
Sadly our RCT was stopped prematurely due to the effect of the COVID19 pandemic on recruitment.
#DAPT duration after #heartattack; DUAL-ACS
5,052 patients, 3 vs 12 mo, open label.
Death at 15 mo: 2.69% vs 3.44%, not significant.
@Heart_BMJ https://t.co/78Vnhdt9Cu
Interested in cardiovascular medicine? Join PCCS Council as our next GP Registrar Representative and bring the trainee voice to PCCS.
Send your CV + a short email to [email protected]
Closes Mon 30 Nov
#GPTrainee#PrimaryCare
Frost on every wall and field, pale light spilling down the dale and not a sound but your own breathing.
The valley below is still asleep and from up here on the Pennine Way, it feels like you have the whole world to yourself.
Would you brave a frosty morning like this for a view like that?
BACPR Reference Tables Booklet – A Handy Resource for Everyday Practice
Looking for quick and easy access to key exercise assessment information?
The BACPR Reference Tables Booklet is a practical resource designed to support healthcare professionals in assessing, monitoring and guiding physical activity and exercise intensity.
With easy-to-use tables for determining target heart rates and MET values, it’s a useful reference to keep close at hand during day-to-day practice.
https://t.co/XFBA9hjY8E.
Our meta analysis…
Models using routine healthcare data to identify risk of undiagnosed VHD show potential, but comprehensive external & prospective validation is required before consideration of implementation.
@ESC_Journals https://t.co/LSoYt8ZbP5
Each word you say is planned by a small patch of brain above your left ear, about a quarter of a second before you say it. It sits in a temporal lobe region textbooks describe as only for listening. Our paper today in @ScienceMagazine: https://t.co/EXOgl3YsNI
@UCSF@NeurosurgUCSF
In this Chinese nationwide registry of 66,192 patients hospitalised with acute pulmonary embolism, by 5 years 22.4% (95% CI 21.9 to 22.9) had died (& nearly half of the deaths were non-cardiovascular, led by #cancer). 🇨🇳 @ehj_ed
https://t.co/iIZk4tkZwC
This is welcome for resident doctors
NHS consultants with academic interests - often leading trials and supervising PhDs - get little or no support.
Proper clinicians are invaluable in research and should be encouraged - especially as excellence awards have been cut and no longer pensionable
University departments more than happy to take their publications in the REF even when they provide no funding or support
Our paper in @ESC_Journals@ehj_ed:
Declining IHD mortality across Western Europe conceals persistent sex-specific differences in population case fatality
Despite improvements in CVD mortality, substantive female excess in MPR was observed in Austria, France, Greece, Israel, Italy, and Spain, whereas substantive male excess was observed only in Iceland
@RBugiardini@cpgale3@EdinaCenko
#TAVI#aorticstenosis#Abbott starts its VOYAGER CE trial of the investigational #Encantor software guided balloon expandable TAVI system.
Single arm study of up to 300 patients with symptomatic severe calcific aortic stenosis in Europe & Australia.
https://t.co/RJA1YzWiAY
#STX1200#Lpa
Scribe Therapeutics reports preclinical data for STX1200, a CRISPR gene editor targeting LPA.
In transgenic LPA mice, one dose under 0.5 mg/kg of an STX1200 prototype reduced serum Apo(a) by over 95%.
https://t.co/rYyc8wUYfx
Today is International Men’s Day.
We’re recruiting a Men’s Health Ambassador to be a national voice for men’s physical and mental health, helping them live longer, healthier and happier lives.
Find out more:
https://t.co/o2yFpKuj8c